Fundz

Precision BioSciences

Durham, North Carolina, United States · Biotechnology, Genetics, Health Care · 106 employees

Precision is a clinical stage gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. Key capabilities and differentiating characteristics may enable ARCUS nucleases to drive more intended, defined therapeutic outcomes. Using ARCUS, Pre

Funding history

  • Funding Round — $7.5M — Mar 2026
  • Funding Round — $66.4M — Nov 2025
  • Funding Round — $7.5M — Feb 2024
  • Funding Round — $39.6M — Mar 2019
  • Funding Round — $88.1M — Jun 2018

Recent signals

  • Mar 02, 2026: Raised $7.5M
  • Nov 12, 2025: Raised $66.4M
  • Nov 10, 2025: SEC 8-K (1.01): On November 10, 2025, Precision BioSciences, Inc. entered into a material definitive underwriting agreement with Guggenheim Securities, LLC for the offering, issuance, and sale of 10,815,000 shares of its common stock at a combined price of $6.14, along with one-half warrants to purchase up to an additional 5,407,500 shares. Additionally, the agreement includes pre-funded warrants to purchase up to 1,400,000 shares for certain investors. This strategic move is intended to strengthen the company's capital position and support its ongoing business initiatives. The transaction's completion and terms signify a crucial fundraising step for Precision BioSciences.
  • Feb 19, 2025: Launched Precision BioSciences Launches PBGENE-HBV to Investigate Safety and Antiviral Activity in Chronic Hepatitis B Patients.
  • Jan 29, 2025: Precision BioSciences Appoints Cindy Atwell as Chief Development and Business Officer and Cassie Gorsuch, PhD as Chief Scientific Officer
  • Oct 16, 2024: Launched Precision BioSciences Announces Presentation at ESGCT Congress Highlighting ARCUS Gene Editing Platform
  • Feb 13, 2024: Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
  • Feb 12, 2024: Raised $7.5M

See plans & pricing → Track Precision BioSciences’s funding, hiring, and signals — with verified contacts — on Fundz.